| |
| |
|
| Insider
Information: |
Alam Kamran |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
840,937 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
840,937 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Taysha Gene Therapies, Inc. |
TSHA |
|
2024-02-02 |
840,937 |
2020-09-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSHA |
Taysha Gene Therapies, In... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-02-02 |
4 |
D |
$1.51 |
$1,945 |
D/D |
(1,288) |
840,937 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
590,413 |
842,225 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2023-08-24 |
4 |
AS |
$2.33 |
$76,890 |
D/D |
(33,000) |
258,042 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,230 |
291,042 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,691 |
284,812 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2022-08-23 |
4 |
AS |
$3.47 |
$11,538 |
D/D |
(3,325) |
266,121 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
AS |
$3.50 |
$34,010 |
D/D |
(9,717) |
269,446 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2022-08-19 |
4 |
AS |
$3.75 |
$43,058 |
D/D |
(11,482) |
279,163 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2022-08-18 |
4 |
AS |
$3.87 |
$28,932 |
D/D |
(7,476) |
290,645 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2021-08-20 |
4 |
AS |
$16.70 |
$198,649 |
D/D |
(11,840) |
298,121 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2021-08-19 |
4 |
AS |
$16.43 |
$164,175 |
D/D |
(9,967) |
309,961 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2021-08-18 |
4 |
AS |
$17.35 |
$194,199 |
D/D |
(11,193) |
319,928 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Chief Financial Officer |
• – – |
2020-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
331,121 |
331,121 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
